121 related articles for article (PubMed ID: 11191832)
1. Pharmacologically elevated levels of endogenous kynurenic acid prevent nicotine-induced activation of nigral dopamine neurons.
Erhardt S; Oberg H; Engberg G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):21-7. PubMed ID: 11191832
[TBL] [Abstract][Full Text] [Related]
2. Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid.
Erhardt S; Hajos M; Lindberg A; Engberg G
Synapse; 2000 Aug; 37(2):104-8. PubMed ID: 10881031
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons.
Erhardt S; Oberg H; Mathé JM; Engberg G
Amino Acids; 2001; 20(4):353-62. PubMed ID: 11452979
[TBL] [Abstract][Full Text] [Related]
4. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.
Erhardt S; Schwieler L; Engberg G
Synapse; 2002 Mar; 43(4):227-37. PubMed ID: 11835517
[TBL] [Abstract][Full Text] [Related]
5. Excitation of nigral dopamine neurons by the GABA(A) receptor agonist muscimol is mediated via release of glutamate.
Erhardt S; Engberg G
Life Sci; 2000 Sep; 67(15):1901-11. PubMed ID: 11043612
[TBL] [Abstract][Full Text] [Related]
6. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
[TBL] [Abstract][Full Text] [Related]
7. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
Erhardt S; Engberg G
Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
Schwieler L; Erhardt S
Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
[TBL] [Abstract][Full Text] [Related]
9. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.
Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S
Int J Neuropsychopharmacol; 2005 Sep; 8(3):329-39. PubMed ID: 15737250
[TBL] [Abstract][Full Text] [Related]
10. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
11. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
12. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
Miranda AF; Sutton MA; Beninger RJ; Jhamandas K; Boegman RJ
Neurosci Lett; 1999 Mar; 262(2):81-4. PubMed ID: 10203236
[TBL] [Abstract][Full Text] [Related]
13. Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents.
Speciale C; Cini M; Wu HQ; Salvati P; Schwarcz R; Molinari A; Calabresi M; Varasi M
Adv Exp Med Biol; 1996; 398():221-7. PubMed ID: 8906269
[No Abstract] [Full Text] [Related]
14. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
[TBL] [Abstract][Full Text] [Related]
15. 28833, a selective kynurenine 3-hydroxylase inhibitor. Effects on the kynurenine pathway metabolites in the gerbil.
Cini M; Bormetti R; Marconi M; Molinari A; Veneroni O; Varasi M; Schwarcz R; Speciale C
Adv Exp Med Biol; 1996; 398():535-8. PubMed ID: 8906318
[No Abstract] [Full Text] [Related]
16. Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid.
Wu HQ; Schwarcz R; Shepard PD
Synapse; 1994 Mar; 16(3):219-30. PubMed ID: 7515199
[TBL] [Abstract][Full Text] [Related]
17. Kynurenic acid and schizophrenia.
Erhardt S; Schwieler L; Engberg G
Adv Exp Med Biol; 2003; 527():155-65. PubMed ID: 15206728
[TBL] [Abstract][Full Text] [Related]
18. Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons.
Nilsson LK; Linderholm KR; Erhardt S
J Neural Transm (Vienna); 2006 May; 113(5):557-71. PubMed ID: 16082514
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
Pierucci M; Di Matteo V; Esposito E
J Pharmacol Exp Ther; 2004 Apr; 309(1):109-18. PubMed ID: 14722316
[TBL] [Abstract][Full Text] [Related]
20. Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats.
Di Matteo V; Pierucci M; Benigno A; Esposito E; Crescimanno G; Di Giovanni G
CNS Neurosci Ther; 2010 Jun; 16(3):127-36. PubMed ID: 20345972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
